Investment
Features
FeesSafety
Academy
More
Pluang+

OpenAI launches GPT-6.1 Sol, a cheaper AI model with improved coding and safety features.

Protocol Fundamentals
29 Sep 2026
Tokenpost
View Source
Bullish
OpenAI launches GPT-6.1 Sol, a cheaper AI model with improved coding and safety features.

OpenAI introduced GPT-6.1 Sol on September 29 as a more affordable AI model priced at one-fifth of GPT-6 Astra's token costs. This new version enhances programming, debugging, document understanding, and multi-step workflows while reducing factual errors and improving adherence to user intent and safety. The GPT-6.1 Astra model was canceled due to safety concerns, and GPT-6.1 Sol is now available for subscribers on various ChatGPT and Codex plans. This launch offers users a cost-effective, reliable AI tool for professional and coding tasks.

OpenAI's launch of GPT-6.1 Sol comes as a backdrop to a mixed market performance among major cryptocurrencies on Pluang. For readers following the crypto sector, here is Pluang's market snapshot as of Sep 29, 2026 23:51 WIB: out of 50 major cryptocurrencies, 21 rose and 28 fell. Notable movers include AXS with a 4.54% gain and a typical hold time of 62 days, LTC down 3.35% with 87% buy order activity, and LINK down 2.68% with 60% buy order activity.

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
22 minutes ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
2 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
3 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
3 hours ago
Silver Elephant Mining ups private placement to raise CAD 882K for working capital.

Silver Elephant Mining ups private placement to raise CAD 882K for working capital.

Silver Elephant Mining Corp. has increased its non-brokered private placement to 7.35 million units at CAD 0.12 each, aiming to raise up to CAD 882,000. Each unit includes one common share and one warrant to buy an additional share at CAD 0.16 within...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App